1003 The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-Cardiac [Enhanced Recovery After Cardiac Surgery] for Postoperative Delirium (POD)

Abstract Introduction Sleep disruption is prevalent among older cardiac surgery patients and has been linked to postoperative delirium (POD) in up to a third of patients. POD is characterized by acute confusion and fluctuating attention, associated with long-term cognitive decline, dementia, prolonged hospitalization and even mortality. Despite this, perioperative interventions targeting sleep remain limited. The Sleep, Cognition, and Pain (SCOPE) bundle aims to reduce POD incidence compared to standard care of Enhanced Recovery After Surgery (ERAS)-cardiac. Methods This is a PCORI-funded randomized controlled trial at four sites (BIDMC, MGH, Columbia and OSU) targeting older patients (≥60 years) undergoing cardiac surgery. Beginning June 2025, 406 will be enrolled over 3 years. Participants are randomized to: 1) Intervention group: sleep optimization and cognitive training starting two weeks prior to surgery, plus eight doses of IV acetaminophen over 48 hours, or 2) Control group: Standard ERAS protocol with three doses over 24 hours. All participants will complete a daily sleep diary and wear an actigraphy before and after surgery. Primary outcome is POD incidence via Confusion Assessment method (CAM) within 7 days of surgery. Secondary outcomes include POD severity and duration, and cognition, functional, sleep, pain, and psychological outcomes up to 1 year after cardiac surgery. Results We will describe recruitment efforts, focus group findings and patient reception to sleep-related interventions thus far. We anticipate that the SCOPE bundle will reducePOD incidence and severity as well as improve recovery compared with standard ERAS care. Challenges are expected in recruitment and retention due to preoperative requirements and the high likelihood of postoperative complications that may affect adherence. Conclusion If effective, the SCOPE bundle will provide the first evidence-based, multimodal intervention to prevent POD in older cardiac surgery patients by optimizing sleep, cognition, and pain, while improving recovery and patient-centered outcomes. Support (if any) This work is supported by the Patient-Centered Outcomes Research Institute (PCORI).

Authors

Institutions

Publication Details

Journal
SLEEP
Published
2026-05-01
DOI
https://doi.org/10.1093/sleep/zsag091.1002
Primary Topic
Intensive Care Unit Cognitive Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

1003 The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-Cardiac [Enhanced Recovery After Cardiac Surgery] for Postoperative Delirium (POD)

Anaëlle Charles, Jason Qu, Andrea Castillo Suarez, Karoline Sanchez Valdes et al.
SLEEP
Intensive Care Unit Cognitive Disorders
article

1003 The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-Cardiac [Enhanced Recovery After Cardiac Surgery] for Postoperative Delirium (POD)

Anaëlle Charles, Jason Qu, Andrea Castillo Suarez, Karoline Sanchez Valdes, Mansi Chhajed, Lei Gao, Mili Jimenez Gallardo
article en

Abstract

Abstract Introduction Sleep disruption is prevalent among older cardiac surgery patients and has been linked to postoperative delirium (POD) in up to a third of patients. POD is characterized by acute confusion and fluctuating attention, associated with long-term cognitive decline, dementia, prolonged hospitalization and even mortality. Despite this, perioperative interventions targeting sleep remain limited. The Sleep, Cognition, and Pain (SCOPE) bundle aims to reduce POD incidence compared to standard care of Enhanced Recovery After Surgery (ERAS)-cardiac. Methods This is a PCORI-funded randomized controlled trial at four sites (BIDMC, MGH, Columbia and OSU) targeting older patients (≥60 years) undergoing cardiac surgery. Beginning June 2025, 406 will be enrolled over 3 years. Participants are randomized to: 1) Intervention group: sleep optimization and cognitive training starting two weeks prior to surgery, plus eight doses of IV acetaminophen over 48 hours, or 2) Control group: Standard ERAS protocol with three doses over 24 hours. All participants will complete a daily sleep diary and wear an actigraphy before and after surgery. Primary outcome is POD incidence via Confusion Assessment method (CAM) within 7 days of surgery. Secondary outcomes include POD severity and duration, and cognition, functional, sleep, pain, and psychological outcomes up to 1 year after cardiac surgery. Results We will describe recruitment efforts, focus group findings and patient reception to sleep-related interventions thus far. We anticipate that the SCOPE bundle will reducePOD incidence and severity as well as improve recovery compared with standard ERAS care. Challenges are expected in recruitment and retention due to preoperative requirements and the high likelihood of postoperative complications that may affect adherence. Conclusion If effective, the SCOPE bundle will provide the first evidence-based, multimodal intervention to prevent POD in older cardiac surgery patients by optimizing sleep, cognition, and pain, while improving recovery and patient-centered outcomes. Support (if any) This work is supported by the Patient-Centered Outcomes Research Institute (PCORI).

SLEEPVol. 49(Supplement_1)
Harvard University (US), Massachusetts General Hospital (US), Center for Pain and the Brain (US)
Good health and well-being
Openalex Percentile: Top 6%
Intensive Care Unit Cognitive Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.